Page 1 of 41
MHA 710 / MHA710 EXAM 2: (LATEST
UPDATES STUDY BUNDLE PACKAGE) QUESTIONS AND
VERIFIED ANSWERS | 100% CORRECT | GRADE A -
LSU
The direct costs in an economic evaluation include the all the
following except: .....ANSWER.....reduced productivity at work
When measuring effectiveness of a treatment, surrogate
measures reflect clinical efficacy and include:
.....ANSWER.....bone-mass density (BMD)
Which of the following measures of effectiveness is not a
surrogate measure? .....ANSWER.....Hip fracture
The intangible costs associated with reduced quality of life
include: .....ANSWER.....Pain and suffering
Suppose that you are asked to use the standard time trade-off
approach to measuring quality of life and are given the
,Page 2 of 41
following information. An individual is faced with living the
remaining 10 years of her life suffering from severe
osteoporosis. She reveals that she would be willing to give up
four of those years to live the remaining six in perfect health.
What is the utility of one year in the chronic health state relative
to perfect health? .....ANSWER.....0.6
Researchers estimate QALYs in a number of different ways. One
popular approach is called the .....ANSWER.....standard gamble
The standard cut-off for cost per QALY is ______ per capita
income. .....ANSWER.....equal to
Cost-effectiveness considerations are more formally integrated
into health policy making in .....ANSWER.....Australia, Europe,
Canada
Steps in performing a cost-effectiveness analysis include all of
these EXCEPT .....ANSWER.....prioritizing the alternative treatment
options
,Page 3 of 41
Researchers use cost-of-illness studies to .....ANSWER.....do all of
the above
(a. study the burden of a disease
b. determine the low-cost option to treat a disease
c. compare two or more treatment options when the medical
outcome is identical
d. increase public awareness of cost of treating certain diseases)
A critical assumption in the model of demand and supply is the
independence of demand and supply curves. If the two are not
independent, a shift in the supply curve can lead to a shift in the
demand curve referred to as .....ANSWER.....supplier-induced
demand.
The top ten causes of death in the United States in 2010 included
all of the following except .....ANSWER.....AIDS
, Page 4 of 41
The accompanying diagram depicts the relationship between
health status and medical care spending for a particular country.
Which of the following statements is true? .....ANSWER.....Social
pressures will move the health care system to spend S2.
Health care that actually harms the patient, such as an adverse
reaction to a prescription drug, is called
.....ANSWER.....iatrogenic disease
The number one cause of death in the United States in 1980 was
.....ANSWER.....heart disease
Health insurance features that tend to reduce moral hazard
include .....ANSWER.....all of the above
(a. deductibles, coinsurance, copayments)
The concept quality-adjusted life year (QALY) .....ANSWER.....is
used extensively to evaluate medical care resource allocation
within government-run programs on fixed budgets, especially in
Europe.
MHA 710 / MHA710 EXAM 2: (LATEST
UPDATES STUDY BUNDLE PACKAGE) QUESTIONS AND
VERIFIED ANSWERS | 100% CORRECT | GRADE A -
LSU
The direct costs in an economic evaluation include the all the
following except: .....ANSWER.....reduced productivity at work
When measuring effectiveness of a treatment, surrogate
measures reflect clinical efficacy and include:
.....ANSWER.....bone-mass density (BMD)
Which of the following measures of effectiveness is not a
surrogate measure? .....ANSWER.....Hip fracture
The intangible costs associated with reduced quality of life
include: .....ANSWER.....Pain and suffering
Suppose that you are asked to use the standard time trade-off
approach to measuring quality of life and are given the
,Page 2 of 41
following information. An individual is faced with living the
remaining 10 years of her life suffering from severe
osteoporosis. She reveals that she would be willing to give up
four of those years to live the remaining six in perfect health.
What is the utility of one year in the chronic health state relative
to perfect health? .....ANSWER.....0.6
Researchers estimate QALYs in a number of different ways. One
popular approach is called the .....ANSWER.....standard gamble
The standard cut-off for cost per QALY is ______ per capita
income. .....ANSWER.....equal to
Cost-effectiveness considerations are more formally integrated
into health policy making in .....ANSWER.....Australia, Europe,
Canada
Steps in performing a cost-effectiveness analysis include all of
these EXCEPT .....ANSWER.....prioritizing the alternative treatment
options
,Page 3 of 41
Researchers use cost-of-illness studies to .....ANSWER.....do all of
the above
(a. study the burden of a disease
b. determine the low-cost option to treat a disease
c. compare two or more treatment options when the medical
outcome is identical
d. increase public awareness of cost of treating certain diseases)
A critical assumption in the model of demand and supply is the
independence of demand and supply curves. If the two are not
independent, a shift in the supply curve can lead to a shift in the
demand curve referred to as .....ANSWER.....supplier-induced
demand.
The top ten causes of death in the United States in 2010 included
all of the following except .....ANSWER.....AIDS
, Page 4 of 41
The accompanying diagram depicts the relationship between
health status and medical care spending for a particular country.
Which of the following statements is true? .....ANSWER.....Social
pressures will move the health care system to spend S2.
Health care that actually harms the patient, such as an adverse
reaction to a prescription drug, is called
.....ANSWER.....iatrogenic disease
The number one cause of death in the United States in 1980 was
.....ANSWER.....heart disease
Health insurance features that tend to reduce moral hazard
include .....ANSWER.....all of the above
(a. deductibles, coinsurance, copayments)
The concept quality-adjusted life year (QALY) .....ANSWER.....is
used extensively to evaluate medical care resource allocation
within government-run programs on fixed budgets, especially in
Europe.
